How much does Olaparib cost in China?

Olaparib is a targeted drug for cancer patients carrying BRCA1 or BRCA2 gene mutations. It is mainly used to treat ovarian cancer, breast cancer, prostate cancer and pancreatic cancer. BRCA gene mutations cause cells to lose the ability to repair DNA double-strand breaks, increasing the risk of cancer. By inhibiting PARP (polyADP-ribose polymerase), a key protein, olaparib further blocks the DNA repair pathway of cancer cells, causing cancer cells to accumulate DNA damage and ultimately trigger their death. Its unique mechanism of action allows it to show significant efficacy in cancer patients carrying BRCA gene mutations, especially those who do not respond well to conventional chemotherapy.

In 2014, Lynparza was first approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced ovarian cancer, especially those carrying BRCA mutations. As clinical trials progress, its indications are gradually expanded to other cancer types, including triple-negative breast cancer and some pancreatic cancers, prostate cancers, etc. Compared with traditional chemotherapy drugs, olaparib, as a targeted therapy, has better tolerance and safety. Common side effects include fatigue, nausea, anemia, and thrombocytopenia, which can usually be controlled through dose adjustment or symptomatic treatment.

In China, Lynparza has been launched and included in the medical insurance directory, significantly reducing the financial burden on patients. Specifically, the price of 150mg*56 tablets of Lynparza in domestic pharmacies is about four to five thousand yuan. After reimbursement by medical insurance, the patient's out-of-pocket ratio is relatively low. However, specific prices and reimbursement ratios may vary from region to region, and patients can consult their local hospital or pharmacy for exact information.

In addition, the prices of generic drugs in some foreign countries such as Bangladesh and Laos are relatively low. The price of generic Lynparza, which is 150mg*120 tablets, is about 2,000 yuan. These generic drugs are basically the same as the domestic original drugs in terms of drug ingredients and efficacy, so they may be a lower-cost option for some patients with limited financial conditions. However, when choosing generic drugs, patients need to carefully evaluate the source and quality of the drugs, and it is recommended to use the drugs under the guidance of professional doctors.